Neoplasms: all 9,610 studies
Page 83 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid MalignanciesCompletedNCT01202370Phase 1
- To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid TumorsCompletedNCT01199224Phase 1
- Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentCompletedNCT01198457
- Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyCompletedNCT01198301
- Excision Limits of Oral Cavity Tumor by Narrow Band ImagingTerminatedNCT01198119Phase 2
- A Study of BEZ235 in Adult Japanese Patients With Advanced Solid TumorsCompletedNCT01195376Phase 1
- A Dose-escalation Study in Subjects With Advanced MalignanciesCompletedNCT01195311Phase 1
- Malignancy Meta Analysis for BRL49653CompletedNCT01195259
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- Dose Escalation of IPI-493 in Hematologic MalignanciesTerminatedNCT01193491Phase 1
- To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid TumorsCompletedNCT01193140Phase 2
- 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid TumorsCompletedNCT01191216Phase 1
- Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory StudyTerminatedNCT01190241Not applicable
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced MalignanciesCompletedNCT01188252Phase 1
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- Exploration of Tumor Accumulation of BAY94-9392 in Patients With CancerCompletedNCT01186601Phase 1
- Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnifeStatus unknownNCT01185483
- Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid TumorsCompletedNCT01184807Phase 1
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid TumorsCompletedNCT01183364Phase 1
- Computed Tomography (CT) Colonography Versus Optical ColonoscopyStatus unknownNCT01181739
- 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and NeurologyStatus unknownNCT01180751Phase 3
- Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled TrialStatus unknownNCT01179724Not applicable
- Effect of Aminobiphosphonates and Statins on Circulating Vgamma9Vdelta2-T CellsCompletedNCT01179464Not applicable
- Early Detection of Cancers in Low Resource CountriesStatus unknownNCT01178736
- Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers SyndromeWithdrawnNCT01178151Phase 2
- Trientine and Carboplatin in Advanced MalignanciesCompletedNCT01178112Phase 1
- Short-Term Fasting Before Chemotherapy in Treating Patients With CancerCompletedNCT01175837Not applicable
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive TractWithdrawnNCT01175499Not applicable
- Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorStatus unknownNCT01175096Phase 1/2
- High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line TherapyStatus unknownNCT01172912Phase 2
- Study of Biomarker From Blood and Tissue of Head and Neck CarcinomaStatus unknownNCT01171235
- Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid TumorsCompletedNCT01170897Phase 1
- Ixabepilone and Pemetrexed/Solid TumorsWithdrawnNCT01170871Phase 1
- Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological MalignanciesWithdrawnNCT01168882Phase 1
- Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic MalignanciesWithdrawnNCT01166529Not applicable
- A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric AdenocarcinomaCompletedNCT01166490Phase 1
- Lenalidomide and Cetuximab in Patients With Advanced Solid TumorsStatus unknownNCT01166035Phase 1/2
- Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid TumorsCompletedNCT01165905Phase 1
- Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid TumorsCompletedNCT01165385Phase 1
- Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerCompletedNCT01164709Phase 1
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseCompletedNCT01164163Phase 1
- Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid TumoursCompletedNCT01163903Phase 1
- T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWithdrawnNCT01163201Phase 1/2
- A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or LymphomasTerminatedNCT01163071Phase 1
- A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard TherapyCompletedNCT01159522Phase 1
- LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid TumorsStatus unknownNCT01159418Phase 1
- First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid TumorCompletedNCT01156870Phase 1
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid TumorsCompletedNCT01155713Phase 1
- Lenalidomide and Paclitaxel in Advanced Solid TumorsStatus unknownNCT01155505Phase 1
- A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor PatientsCompletedNCT01155453Phase 1
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMICStatus unknownNCT01154270Phase 2
- Bendamustine and Bevacizumab for Advanced CancersCompletedNCT01152203Phase 1
- Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
- Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid TumorsCompletedNCT01151384Phase 1
- Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid TumorsCompletedNCT01149720Phase 1
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNCT01148160
- GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to TherapyTerminatedNCT01147029Phase 1
- Trial to Evaluate Single- and Double- Freeze Cryotherapy in the Prevention of Cervical NeoplasiaCompletedNCT01145781Not applicable
- Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast CancerCompletedNCT01143974Phase 4
- Role of Intraoperative Ultrasound in Gastrointestinal (GI) MalignanciesStatus unknownNCT01143922
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA DamageCompletedNCT01143519
- Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study DrugCompletedNCT01141257Phase 1
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01141244Phase 1
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCompletedNCT01140607Phase 1
- Study of Oral Darinaparsin in Patients With Advanced Solid TumorsCompletedNCT01139346Phase 1
- 4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNCT01139151Phase 1
- A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid TumorsTerminatedNCT01137552Phase 1
- Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
- Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
- An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal CancerTerminatedNCT01134666
- Dose Escalation Study of AUY922 in Advanced Solid Malignancies in JapanCompletedNCT01132625Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWithdrawnNCT01130623Phase 1
- Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid TumorsCompletedNCT01129349Phase 1
- Sorafenib Plus S-1 in Advanced Solid TumorsCompletedNCT01128998Phase 1
- Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid TumorsCompletedNCT01125891Phase 1
- Confocal Laser Endomicroscopy and Endoscopic Mucosal ResectionCompletedNCT01124994Not applicable
- Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)CompletedNCT01124214Not applicable
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeTerminatedNCT01122888Phase 1
- Tomotherapy in Locally Advanced Gallbladder and Pancreatic CancersCompletedNCT01118897Phase 1/2
- Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard TherapiesTerminatedNCT01118819Phase 1
- Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid TumorsCompletedNCT01118611Phase 1
- Biomarkers in Tissue Samples From Patients With High-Risk Wilms TumorCompletedNCT01118078
- Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFUCompletedNCT01117246Phase 1/2
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology GroupActive, not recruitingNCT01117168
- An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+TerminatedNCT01116245Phase 2
- A Phase 1 Study in Participants With Advanced CancerCompletedNCT01115790Phase 1
- Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung MetastasesCompletedNCT01114958Phase 1
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid TumoursTerminatedNCT01112397Phase 1
- Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research NetworkCompletedNCT01112280Not applicable
- Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal NeoplasmsStatus unknownNCT01112046Phase 3
- A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)TerminatedNCT01110603Phase 1
- ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid TumorsCompletedNCT01110486Phase 1
- Trial Of Cisplatin And KML-001 in Platinum Responsive MalignanciesTerminatedNCT01110226Phase 1
- First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid TumorsTerminatedNCT01110083Phase 1